Tag: glp-1

Chargebacks & Fraud

GLP-1 Telehealth Sellers Face Patients Told to Check the Dispensing Pharmacy First

USA Today's October 21 guide sends GLP-1 patients to state pharmacy license lookups, PCAB or CCE accreditation checks, and FDA's compounding actions list. An analysis of what telehealth sellers can disclose about the dispensing pharmacy to build trust and limit disputes.

E-commerce 4 Internet Marketers Editorial
High-Risk Merchant Accounts

Eli Lilly Presses Card Companies and Processors to Cut Off Retatrutide Sellers

Eli Lilly's six retatrutide lawsuits came with a call for card companies and processors to cut off sellers, and a CBS News investigation then found more than 80 businesses promoting the unapproved drug under LegitScript's seal, raising the bar for licensed telehealth and compounding merchants in underwriting.

E-commerce 4 Internet Marketers Editorial
FDA & Product Rules

FDA Peptide Warning Letters Show Research Use Only Labels Did Not Shield Online Vendors

FDA's August 24, 2026 warning letters to Peak Performance Peptides, Royal Peptides, NuScience Peptides, Peptide Partners, and Tex Peptides set aside research use only disclaimers and list the product pages, study summaries, blog posts, calculators, and bacteriostatic water that FDA treated as evidence of intended human use.

E-commerce 4 Internet Marketers Editorial